A study to investigate the prevalence of Metabolic Syndrome in Stable Chronic Obstructive Pulmonary Disease patients

Dr Sachin Kumar Gupta; Dr Aashish Kumar Singh

Volume : IX, Issue : II, February - 2020

A study to investigate the prevalence of Metabolic Syndrome in Stable Chronic Obstructive Pulmonary Disease patients

Dr Sachin Kumar Gupta, Dr Aashish Kumar Singh

Abstract :

Background: Chronic Obstructive Pulmonary Disease (COPD) is associated with several extra-pulmonary systemic manifestations including metabolic syndrome. Metabolic syndrome is an aggregate of inter-related cardio-metabolic risk factors, comprising glucose intolerance, abdominal obesity, dyslipidemia and hypertension, which are associated with an increased risk of cardiovascular disease and type-2 diabetes. The objective of study was to assess prevalence of metabolic syndrome among COPD patients. Methods: This cross-sectional study was conducted from April 2017 to March 2018. Total 67 COPD patients were classified according to GOLD guideline. International Diabetes Federation (IDF) guideline was used for metabolic syndrome(MetS). Results: Prevalence of MetS was 29.85%, highest (47.06%) in GOLD stage-II, followed by stage-I (40%). Conclusions: The presence of metabolic syndrome is common in patients with COPD and all COPD patients should be considered for its screening.